ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy

Status Completed

Clinical Trial Summary

Clinical observation to confirm the clinical safety and efficacy of ODM 5 in the treatment of corneal edema caused by Fuchs' endothelial dystrophy.

Clinical Trial Description

Patients with a Fuchs' endothelial dystrophy-induced corneal edema and an ODM 5 therapy recommendation prior to their inclusion will be observed in normal practice setting in this post-market clinical follow-up study. In this indication, the use of ODM 5 should extract the fluid excess in the cornea away by an osmotic effect, enabling the cornea to temporarily regain a normal state of hydration. As a consequence, the patient's visual acuity, contrast perception, corneal thickness and ocular complaints/symptoms should improve. The hyaluronan in ODM 5 helps to protect and heal the cornea in case of irritation and thus, enables the cornea to regain a normal state of hydration and participates in improving the quality of vision. ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02332109
Study type	Observational
Source	TRB Chemedica AG
Contact
Status	Completed
Phase	N/A
Start date	September 2015
Completion date	May 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03248037` - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation	Phase 3
Recruiting	`NCT03275896` - Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy	Early Phase 1
Completed	`NCT02470793` - Technique And Results In Endothelial Keratoplasty	N/A
Recruiting	`NCT01206127` - DSAEK- Postoperative Positioning and Transplant Dislocation	N/A
Recruiting	`NCT03407755` - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)	N/A
Completed	`NCT04140422` - Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea	N/A
Recruiting	`NCT06048380` - The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery	Phase 3
Completed	`NCT02793310` - DMEK Versus DSAEK Study	N/A
Completed	`NCT01795001` - The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Completed	`NCT04057053` - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty	Early Phase 1
Terminated	`NCT01361282` - Using the Optovue OCT to Select IOL Power	N/A
Completed	`NCT02542644` - Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT	N/A
Recruiting	`NCT04191629` - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema	Phase 1
Completed	`NCT05399095` - Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty	N/A
Completed	`NCT04752020` - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty	Early Phase 1
Not yet recruiting	`NCT05716945` - The OPTIMISE Study	Phase 4
Recruiting	`NCT03575130` - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy	Phase 2
Recruiting	`NCT02118922` - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Completed	`NCT04420429` - The Effect Of Preoperative Parameters On Success After DMEK Surgery
Withdrawn	`NCT04018417` - Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.	Phase 2/Phase 3